| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1031217610 |
| P356 | DOI | 10.1186/1465-9921-12-7 |
| P932 | PMC publication ID | 3032684 |
| P698 | PubMed publication ID | 21232087 |
| P5875 | ResearchGate publication ID | 49752631 |
| P50 | author | Tzahit Simon-Tuval | Q59674064 |
| P2093 | author name string | Steven M Scharf | |
| Ariel Tarasiuk | |||
| Barbara J Bernhard-Scharf | |||
| Haim Reuveni | |||
| Nimrod Maimon | |||
| Tzahit Simon-Tuval | |||
| P2860 | cites work | Economic implications of comorbid conditions among Medicaid beneficiaries with COPD. | Q48380183 |
| Elevated healthcare utilisation in young adult males with obstructive sleep apnoea. | Q48456074 | ||
| Factors affecting chronic obstructive pulmonary disease (COPD)-related costs: a multivariate analysis of a Swedish COPD cohort. | Q51123840 | ||
| Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease | Q22299313 | ||
| Standardization of Spirometry, 1994 Update. American Thoracic Society | Q29547574 | ||
| Health care utilization in chronic obstructive pulmonary disease. A case-control study in a health maintenance organization | Q34041644 | ||
| Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases | Q34439990 | ||
| Sleep quality predicts quality of life in chronic obstructive pulmonary disease | Q34554803 | ||
| Epidemiology and costs of chronic obstructive pulmonary disease. | Q34563833 | ||
| Influence of anxiety on health outcomes in COPD. | Q35034814 | ||
| Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease | Q36183957 | ||
| Mortality in COPD: Role of comorbidities. | Q36670236 | ||
| Sleep abnormalities and treatment in emphysema | Q37103709 | ||
| Depression and health-related quality of life in chronic obstructive pulmonary disease | Q37298668 | ||
| Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity | Q37367648 | ||
| Elevated economic burden in obstructive lung disease patients with concomitant sleep apnea syndrome | Q37502767 | ||
| The complex interrelationships between chronic lung and liver disease: a review | Q37729353 | ||
| The economic burden of COPD. | Q40778466 | ||
| Cost analysis of an integrated care model in the management of acute exacerbations of chronic obstructive pulmonary disease | Q43956095 | ||
| Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations | Q43963238 | ||
| Comorbidity, hospitalization, and mortality in COPD: results from a longitudinal study. | Q43973658 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 7 | |
| P577 | publication date | 2011-01-13 | |
| P1433 | published in | Respiratory Research | Q7315904 |
| P1476 | title | Determinants of elevated healthcare utilization in patients with COPD | |
| P478 | volume | 12 |
| Q47570441 | An official American Thoracic Society workshop report: the Integrated Care of The COPD Patient |
| Q26786812 | COPD and its comorbidities: Impact, measurement and mechanisms |
| Q38803051 | COPD: Health Care Utilisation Patterns with Different Disease Management Interventions. |
| Q37253959 | Characteristics and Trends in Hypnotics Consumption in the Largest Health Care System in Israel |
| Q39362105 | Chronic obstructive pulmonary disease and associated healthcare resource consumption in the Middle East and North Africa: the BREATHE study |
| Q36237935 | Contribution of the environment and comorbidities to chronic obstructive pulmonary disease phenotypes |
| Q33755164 | Daily activity during stability and exacerbation of chronic obstructive pulmonary disease |
| Q38068458 | Delivering cost-effective care for COPD in the USA: recent progress and current challenges. |
| Q36980698 | Disproportionate utilization of healthcare resources among veterans with COPD: a retrospective analysis of factors associated with COPD healthcare cost |
| Q35825585 | Economic Burden of COPD in the Presence of Comorbidities. |
| Q34622570 | Efficacy of multiparametric telemonitoring on respiratory outcomes in elderly people with COPD: a randomized controlled trial |
| Q26828976 | Excess costs of comorbidities in chronic obstructive pulmonary disease: a systematic review |
| Q35966442 | Health care charges for youth with newly diagnosed epilepsy |
| Q38119867 | Heart failure and chronic obstructive pulmonary disease: the challenges facing physicians and health services |
| Q33795984 | Impact of Nonadherence to Inhaled Corticosteroid/LABA Therapy on COPD Exacerbation Rates and Healthcare Costs in a Commercially Insured US Population |
| Q37669183 | Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population |
| Q42701518 | Joint statement for the diagnosis, management, and prevention of chronic obstructive pulmonary disease for Gulf Cooperation Council countries and Middle East-North Africa region, 2017. |
| Q27005858 | Managing comorbidities in COPD |
| Q35103337 | Patterns and determinants of COPD-related healthcare utilization by severity of airway obstruction in Korea |
| Q41983099 | Quality of Life Changes and Health Care Charges Among Youth With Epilepsy |
| Q35658506 | Relationship between health-related quality of life, comorbidities and acute health care utilisation, in adults with chronic conditions |
| Q35852488 | Short-term outcomes in heart failure patients with chronic obstructive pulmonary disease in the community |
| Q47128813 | The contribution of symptoms and comorbidities to the economic impact of COPD: an analysis of the German COSYCONET cohort |
| Q37351376 | The impact of COPD on health status: findings from the BOLD study |
| Q46019872 | The use of age-period-cohort analysis to determine the impact of economic development on COPD mortality in Hong Kong. |
| Q50601223 | Tiotropium as part of inhaled polytherapy: adherence and associated health-care utilization. |
| Q89939217 | Using the BODE Index and Comorbidities to Predict Health Utilization Resources in Chronic Obstructive Pulmonary Disease |
Search more.